Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

Core Insights - Nexalin Technology, Inc. has successfully completed and launched phases one through five of its proprietary virtual clinic and digital research ecosystem, which supports data capture, remote monitoring, and virtual treatment with its HALO™ headset [1][2][3] Group 1: Virtual Clinic Launch - The virtual clinic was launched at the University of California, San Diego (UCSD) to facilitate patient recruitment for a military study on TBI/PTSD [1] - The platform enables real-time data capture and clinical oversight, allowing patients to receive treatment in their homes while ensuring compliance with research protocols [1][2] Group 2: Digital Infrastructure - Nexalin has established a comprehensive digital infrastructure that includes an AI-integrated Electronic Data Capture (EDC) platform and a Patient Monitoring System (PMS) [2][7] - This infrastructure enhances capabilities for remote research studies and streamlines patient care using non-invasive DIFS™ technology [2][4] Group 3: Clinical Research and Treatment - The virtual clinic facilitates clinical research on the HALO™ device, focusing on mental health disorders, traumatic brain injury, addiction, and neurodegenerative conditions [3][4] - The system allows for remote monitoring of treatment adherence and tracking of patient outcomes, optimizing clinical protocols [4][7] Group 4: Future Prospects - The completion of the virtual clinic positions Nexalin to expand research collaborations, advance regulatory approvals, and accelerate commercialization efforts for HALO™ and future DIFS™ technology applications [4]